GlaxoSmithKline Pharmaceuticals Limited (GLAXO.BO) Stock Price, News & Chart

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close2,532.60

Open2,550.00

Day range2,495.552,570.55

52-week range1,968.003,515.95

Off day high−2.72%

Off 52-week high−28.88%

Volume54.97K

Avg. volume (3M)4.37K

Market cap423.63B

EPS (TTM)56.30

Forward P/E36.90

P/E ratio (TTM)44.42

Dividend yield1.75% (42.00)

Beta (5Y)-0.05

Shares outstanding169.41M

Short interest—

Earnings dateJul 31, 2025 (est.)

Analyst target2,943.25

Profit margin25.76%

Against its peers

Compare in full ›

	GLAXO.BO	GSK	PFE	MRK	GILD	AZN
Market cap	423.63B	102.53B	175.50B	370.96B	216.41B	293.14B
P/E (TTM)	44.4	17.8	44.0	151.9	—	26.7
Forward P/E	36.9	10.3	10.6	16.7	17.3	16.7
Price/book	24.8	4.1	2.1	8.9	16.6	5.7
Dividend yield	1.75%	3.55%	5.59%	2.26%	1.88%	1.69%
1-year change	+6.17%	+8.60%	+23.90%	+75.29%	+41.39%	+12.81%
Today	−1.26%	+5.03%	+2.63%	+3.93%	+4.19%	+2.79%

The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to GlaxoSmithKline Pharmaceuticals's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
GSK plcGSK · Drug Manufacturers - General	102.53B	51.15	+5.03%
Pfizer Inc.PFE · Drug Manufacturers - General Odds	175.50B	30.79	+2.63%
Merck & Co., Inc.MRK · Drug Manufacturers - General	370.96B	150.36	+3.93%
Gilead Sciences, Inc.GILD · Drug Manufacturers - General Odds	216.41B	174.48	+4.19%
AstraZeneca PLCAZN · Drug Manufacturers - General	293.14B	189.01	+2.79%
SanofiSNY · Drug Manufacturers - General	113.74B	47.47	+4.72%
Biogen Inc.BIIB · Drug Manufacturers - General	37.61B	254.46	+2.22%

Other companies in Drug Manufacturers - General, closest in size first.

Company	Mkt cap	Price	Today
Merck & Co., Inc.MRK · Rahway, NJ	370.96B	150.36	+3.93%
AbbVie Inc.ABBV · North Chicago, IL	521.00B	294.83	+3.09%
Roche Holding AGRHO.DE · Basel, Switzerland	348.82B	437.80	0.00%
Santen Pharmaceutical Co., Ltd.4536.T · Kita, Japan	604.65B	1,882.00	+4.79%
Novartis AGNVS · Basel, Switzerland	311.59B	164.98	+3.59%
AstraZeneca PLCAZN · Cambridge, United Kingdom	293.14B	189.01	+2.79%
Bristol-Myers Squibb CompanyBMYB34.SA · Princeton, NJ	696.42B	340.70	0.00%
Johnson & JohnsonJNJ · New Brunswick, NJ	665.19B	276.32	+3.81%

Healthcare companies of a similar market value (428.32B).

Company	Mkt cap	Price	Today
Alfresa Holdings Corporation2784.T · Medical Distribution	441.07B	2,514.50	+3.73%
Kusuri No Aoki Holdings Co., Ltd.3549.T · Pharmaceutical Retailers	473.96B	4,991.00	+9.07%
BioNTech SEBNTXN.MX · Biotechnology	423.96B	1,710.00	0.00%
WuXi AppTec Co., Ltd.603259.SS · Diagnostics & Research	468.77B	154.46	+3.80%
Ajanta Pharma LimitedAJANTPHARM.NS · Drug Manufacturers - Specialty & Generic	410.69B	3,286.60	−0.91%
GC Corp.005250.KS · Biotechnology	438.13B	9,690.00	+1.47%
Sundrug Co.,Ltd.9989.T · Pharmaceutical Retailers	450.50B	3,851.00	+5.83%
Emcure Pharmaceuticals LimitedEMCURE.BO · Drug Manufacturers - Specialty & Generic	424.98B	2,240.15	+3.02%

Also based in Mumbai, India, then elsewhere in India.

Company	Mkt cap	Price	Today
ICICI Bank LimitedIBN.BA · Mumbai, India	188.59T	52,525.00	+4.48%
Reliance Industries LimitedRELIANCE.BO · Mumbai, India	17.78T	1,313.35	+0.08%
HDFC Bank LimitedHDFCBANK.NS · Mumbai, India	11.73T	760.00	+3.16%
State Bank of IndiaSBIN.NS · Mumbai, India	9.29T	1,006.40	+2.80%
Tata Consultancy Services LimitedTCS.BO · Mumbai, India	9.02T	2,493.00	+2.38%
Larsen & Toubro LimitedLT.BO · Mumbai, India	5.56T	4,042.10	+2.69%
Life Insurance Corporation of IndiaLICI.NS · Mumbai, India	5.16T	408.00	0.00%
Hindustan Unilever LimitedHINDUNILVR.NS · Mumbai, India	4.66T	1,982.00	+0.25%

Companies that serve the same markets: healthcare, media & entertainment.

Company	Mkt cap	Price	Today
GSK plcGSK.L · media & entertainment · healthcare	75.67B	1,887.59	−0.13%
Becton, Dickinson and CompanyBOX.F · media & entertainment · healthcare	50.64B	185.90	−0.19%
CGN Nuclear Technology Development Co., Ltd.000881.SZ · media & entertainment · healthcare	5.91B	6.25	+2.12%
Danaher CorporationDHER34.SA · media & entertainment · healthcare	896.98B	45.57	−3.04%
Thermo Fisher Scientific Inc.TMOS34.SA · media & entertainment · healthcare	1.43T	80.15	+0.29%
Choksi Asia LimitedCHOKSI.BO · media & entertainment · healthcare	1.21B	211.85	+0.88%
Teijin LimitedTIJ.F · media & entertainment · healthcare	2.01B	10.40	+16.20%
Virinchi LimitedVIRINCHI.BO · media & entertainment · healthcare	1.63B	14.45	+0.35%

What visitors to GlaxoSmithKline Pharmaceuticals's page also look at.

Company	Mkt cap	Price	Today
PFIZER LTD.PFIZER.BO	176.60B	3,856.20	+0.62%
TORRENT PHARMACEUTICALS LTD.TORNTPHARM.BO	1.60T	4,717.95	−0.25%
ABBOTT INDIA LTD.ABBOTINDIA.BO	565.08B	26,592.70	−2.04%
SANOFI INDIA LTDSANOFI.BO	77.83B	3,379.40	+0.11%
IPCA LABORATORIES LTD.IPCALAB.BO	494.67B	1,949.80	−1.18%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All GLAXO.BO news ›

Kalkine India·19h agoPositive

GlaxoSmithKline Pharmaceuticals NSE:GLAXO Analyst Meet 2026

Kalkine India GlaxoSmithKline Pharmaceuticals (NSE:GLAXO): What Did the Analyst Meet Recording Disclose? Source: Krish Capital Pty Ltd GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) submitted a regulatory filing on 4 November 2026, di

LLY MRK GSK NVDA

Multibagg AI·1d agoPositive

GlaxoSmithKline Pharmaceuticals Sets November 3 Results Review

GlaxoSmithKline Pharmaceuticals Limited is scheduled to review financial results at a board meeting on November 3, 2026. The company’s calendar disclosure, released on October 13, identifies the financial-results review as the key agenda…

GSK PFE NVO RPRX

InvestyWise·1d agoPositive

GlaxoSmithKline Pharmaceuticals reports Q2 FY27 results and key appointments

GlaxoSmithKline Pharmaceuticals announced its unaudited financial results for the second quarter and half year ended September 30, 2026. The company also informed about the appointment of a new Head of Ethics & Compliance and the approval…

GSK ABOS

From the 4Search news index, newest first.

In the news

4mentions in 30 days

4with it in the headline

Positivesentiment

Most coverage from

investywise.com2
kalkine.co.in1
multibagg.ai1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.